BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 25754154)

  • 1. Increased risk after noninvasive prenatal screening on cell-free DNA circulating in maternal blood: does a new indication for invasive prenatal diagnosis require new criteria for confirmatory cytogenetic analysis?
    Grati FR; Malvestiti F; Grimi B; Liuti R; Agrati C; Gaetani E; Milani S; Martinoni L; Zanatta V; Gallazzi G; Maggi F; Simoni G
    Prenat Diagn; 2015 Mar; 35(3):308-9. PubMed ID: 25754154
    [No Abstract]   [Full Text] [Related]  

  • 2. Noninvasive prenatal screening for aneuploidy: positive predictive values based on cytogenetic findings.
    Meck JM; Kramer Dugan E; Matyakhina L; Aviram A; Trunca C; Pineda-Alvarez D; Aradhya S; Klein RT; Cherry AM
    Am J Obstet Gynecol; 2015 Aug; 213(2):214.e1-5. PubMed ID: 25843063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for fetal aneuploidy.
    Rink BD; Norton ME
    Semin Perinatol; 2016 Feb; 40(1):35-43. PubMed ID: 26725144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing.
    Dar P; Curnow KJ; Gross SJ; Hall MP; Stosic M; Demko Z; Zimmermann B; Hill M; Sigurjonsson S; Ryan A; Banjevic M; Kolacki PL; Koch SW; Strom CM; Rabinowitz M; Benn P
    Am J Obstet Gynecol; 2014 Nov; 211(5):527.e1-527.e17. PubMed ID: 25111587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of random massively parallel sequencing for non-invasive prenatal detection of common autosomal aneuploidies: a collaborative study in Europe.
    Stumm M; Entezami M; Haug K; Blank C; Wüstemann M; Schulze B; Raabe-Meyer G; Hempel M; Schelling M; Ostermayer E; Langer-Freitag S; Burkhardt T; Zimmermann R; Schleicher T; Weil B; Schöck U; Smerdka P; Grömminger S; Kumar Y; Hofmann W
    Prenat Diagn; 2014 Feb; 34(2):185-91. PubMed ID: 24222400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
    Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CLINICAL IMPLEMENTATION OF CELL-FREE DNA ANALYSIS IN MATERNAL BLOOD IN SCREENING FOR ANEUPLOIDIES IN SINGLETON PREGNANCIES].
    Chaveeva P; Yankova M; Stratieva V; Dimitrov I; Shterev A
    Akush Ginekol (Sofiia); 2016; 55(2):10-5. PubMed ID: 27509651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microarray analysis: elegant, accurate, and expensive.
    Wenstrom KD
    Obstet Gynecol; 2014 Aug; 124(2 Pt 1):199-201. PubMed ID: 25004356
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
    Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population - a systematic review and meta-analysis.
    Iwarsson E; Jacobsson B; Dagerhamn J; Davidson T; Bernabé E; Heibert Arnlind M
    Acta Obstet Gynecol Scand; 2017 Jan; 96(1):7-18. PubMed ID: 27779757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reflex antenatal DNA screening for Down syndrome.
    Wald NJ; Huttly WJ; Bestwick JP; Aquilina J; Peregrine E
    Prenat Diagn; 2015 Nov; 35(11):1154. PubMed ID: 26211510
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.
    Gil MM; Quezada MS; Revello R; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Mar; 45(3):249-66. PubMed ID: 25639627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive chromosome test raises new questions in prenatal diagnosis about the significance of ultrasound and questions about new screening strategies.
    Tercanli S; Vial Y; Merz E
    Ultraschall Med; 2013 Oct; 34(5):417-20. PubMed ID: 24127381
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies.
    Zhang H; Gao Y; Jiang F; Fu M; Yuan Y; Guo Y; Zhu Z; Lin M; Liu Q; Tian Z; Zhang H; Chen F; Lau TK; Zhao L; Yi X; Yin Y; Wang W
    Ultrasound Obstet Gynecol; 2015 May; 45(5):530-8. PubMed ID: 25598039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive cell-free fetal DNA testing for trisomy 13 reveals confined placental mosaicism.
    Hall AL; Drendel HM; Verbrugge JL; Reese AM; Schumacher KL; Griffith CB; Weaver DD; Abernathy MP; Litton CG; Vance GH
    Genet Med; 2013 Sep; 15(9):729-32. PubMed ID: 23492874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RETIRED: Current status in non-invasive prenatal detection of Down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma.
    Langlois S; Brock JA;
    J Obstet Gynaecol Can; 2013 Feb; 35(2):177-181. PubMed ID: 23470070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-Free DNA Analysis of Targeted Genomic Regions in Maternal Plasma for Non-Invasive Prenatal Testing of Trisomy 21, Trisomy 18, Trisomy 13, and Fetal Sex.
    Koumbaris G; Kypri E; Tsangaras K; Achilleos A; Mina P; Neofytou M; Velissariou V; Christopoulou G; Kallikas I; González-Liñán A; Benusiene E; Latos-Bielenska A; Marek P; Santana A; Nagy N; Széll M; Laudanski P; Papageorgiou EA; Ioannides M; Patsalis PC
    Clin Chem; 2016 Jun; 62(6):848-55. PubMed ID: 27117469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating fetal cell-free DNA fractions differ in autosomal aneuploidies and monosomy X.
    Rava RP; Srinivasan A; Sehnert AJ; Bianchi DW
    Clin Chem; 2014 Jan; 60(1):243-50. PubMed ID: 24046201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA sequencing versus standard prenatal aneuploidy screening.
    Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
    N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.